人慢性肝病中肝细胞核因子4α活性进行性丧失
研究构建了可准确判定肝细胞核因子4α(HNF4α)活性的靶基因标签,并对包含超过3500份独立样本的30个数据集进行计算机分析。结果显示,HNF4α活性在HCV和HBV相关肝硬化、NAFLD/NASH及肝细胞癌等慢性肝病各进展阶段呈阶梯式下降,且与Child-Pugh分级进展、更快失代偿、肝细胞癌发生及更低生存相关。
要点
- HNF4α活性随慢性肝病各进展阶段呈阶梯式下降。
- 肝硬化中HNF4α活性丧失与Child-Pugh分级进展、更快失代偿、肝细胞癌发生及更低生存相关。
- 肝细胞癌中HNF4α活性丧失与晚期疾病、炎症改变增加、门静脉血栓及显著更低生存相关。
核心结论
- HNF4α功能丧失是慢性肝病进展至肝细胞癌发病过程中的常见事件,在诊断和治疗上均具有重要意义。
研究设计与样本
- 研究构建了HNF4α靶基因标签以准确判定HNF4α活性,并对包含超过3500份独立样本的30个数据集进行层次聚类、K均值聚类、生存分析和秩次分析的计算机分析。
主要发现
- HNF4α活性在HCV和HBV相关肝硬化、NAFLD/NASH及肝细胞癌等慢性肝病各进展阶段呈阶梯式下降。
- 肝硬化基因表达数据集的聚类分析显示,HNF4α活性丧失与Child-Pugh分级进展、更快失代偿、肝细胞癌发生及伴或不伴肝细胞癌的更低生存相关。
- NAFLD中HNF4α活性较正常肝脏呈中度下降,而从NAFLD进展至NASH患者中观察到进一步显著下降。
- 肝细胞癌中HNF4α活性丧失与晚期疾病、炎症改变增加、门静脉血栓及显著更低生存相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Hepatocyte nuclear factor 4 alpha (HNF4α) is indispensable for hepatocyte differentiation and critical for maintaining liver health. Here, we demonstrate that loss of HNF4α activity is a crucial step in the pathogenesis of chronic liver diseases (CLDs) that lead to development of HCC. APPROACH AND RESULTS: We developed an HNF4α target gene signature, which can accurately determine HNF4α activity, and performed an exhaustive in silico analysis using hierarchical and K-means clustering, survival, and rank-order analysis of 30 independent data sets containing over 3500 individual samples. The association of changes in HNF4α activity to CLD progression of various etiologies, including HCV- and HBV-induced liver cirrhosis (LC), NAFLD/NASH, and HCC, was determined. Results revealed a step-wise reduction in HNF4α activity with each progressive stage of pathogenesis. Cluster analysis of LC gene expression data sets using the HNF4α signature showed that loss of HNF4α activity was associated with progression of Child-Pugh class, faster decompensation, incidence of HCC, and lower survival with and without HCC. A moderate decrease in HNF4α activity was observed in NAFLD from normal liver, but a further significant decline was observed in patients from NAFLD to NASH. In HCC, loss of HNF4α activity was associated with advanced disease, increased inflammatory changes, portal vein thrombosis, and substantially lower survival. CONCLUSIONS: In conclusion, these data indicate that loss of HNF4α function is a common event in the pathogenesis of CLDs leading to HCC and is important from both diagnostic and therapeutic standpoints.
引用
- Gunewardena S, Huck I, Walesky C, et al. Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans. Hepatology. 2022. PMID: 35006629. doi:10.1002/hep.32326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。